Daly Jason B.
EVP, Chief Legal Officer
Daly Jason B. has filed 2 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Daly Jason B. is listed as EVP, Chief Legal Officer at Amneal Pharmaceuticals, Inc. Inside the rolling window, Daly Jason B. reported no open-market purchases and 2 open-market sales totaling $3.8M in AMRX. The largest disclosed transaction in the window is a sale of 210,000 AMRX shares on Aug 12, 2026, worth $3.7M.
Companies traded
Other insiders at AMRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Daly Jason B. made?
Daly Jason B. has filed 2 SEC Form 4 filings (12 transaction rows) across 1 company since 2026.
Which companies does Daly Jason B. trade?
Daly Jason B. has filed SEC Form 4 disclosures for 1 company, including AMRX.
When was Daly Jason B.'s most recent SEC Form 4 filing?
Daly Jason B.'s most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Daly Jason B.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Daly Jason B. is listed as EVP, Chief Legal Officer.
What is Daly Jason B.'s total buy and sell value in the current window?
Inside the rolling retention window, Daly Jason B. bought $0 and sold $3.8M based on SEC Form 4 filings.
What was Daly Jason B.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 210,000 AMRX shares on 2026-08-12, worth $3.7M, per SEC Form 4 filings.